The contribution of hybrid SPECT/CT imaging in the management of differentiated thyroid carcinoma

被引:4
作者
Mhiri, A. [1 ,2 ]
Slim, I. [1 ,2 ]
Ghezaiel, M. [1 ,2 ]
Meddeb, I. [1 ,2 ]
El Bez, I. [1 ,2 ]
Yeddes, I. [1 ,2 ]
Gritli, S. [1 ]
Ben Slimene, M. F. [1 ,2 ]
机构
[1] Univ Tunis El Manar, Fac Med Tunis, Tunis 1007, Tunisia
[2] Inst Salah Azaiez, Serv Med Nucl, Tunis 1006, Tunisia
来源
MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE | 2012年 / 36卷 / 10期
关键词
Differentiated thyroid carcinoma; SPECT/CT; Planar scintigraphy; Iodine; 131; COMPUTED TOMOGRAPHY/COMPUTED TOMOGRAPHY; FOLLOW-UP; CT; IMPACT; PATIENT; IMAGES; FUSION;
D O I
10.1016/j.mednuc.2012.08.008
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Introduction. Single photon emission computed tomography combined with a low dose computed tomography (SPECT/CT), is a hybrid imaging integrating functional and anatomical data. The purpose of our study was to evaluate the contribution of the SPECT/CT over traditional planar imaging of patients with differentiated thyroid carcinoma (DTC). Methods. Post-therapy iodine 131 (I-131) whole-body scan followed by cervico-thoracic SPECT/CT, were performed in 100 patients with DTC. Results. Among these 100 patients followed for a predominantly papillary DTC, planar imaging and SPECT/CT, were perfectly concordant in 70% of patients and discordant in the remaining 30%. The use of fusion imaging SPECT/CT compared to conventional planar imaging allowed us to correct our therapeutic approach in 27% (27/100 patients), according to the protocols of therapeutic management of our institute. Conclusion. SPECT/CT is a hybrid imaging modality which provides better identification and more correct anatomic localization of the foci of radioiodine uptake with impact on therapeutic management. (C) 2012 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:554 / 560
页数:7
相关论文
共 50 条
  • [21] SPECT/CT imaging in children with papillary thyroid carcinoma
    Hwa-Young Kim
    Michael J. Gelfand
    Susan E. Sharp
    Pediatric Radiology, 2011, 41 : 1008 - 1012
  • [22] Hybrid SPECT/CT: the end of "unclear" medicine
    Patel, C. N.
    Chowdhury, F. U.
    Scarsbrook, A. F.
    POSTGRADUATE MEDICAL JOURNAL, 2009, 85 (1009) : 606 - 613
  • [23] SPECT/CT in the Treatment of Differentiated Thyroid Cancer
    Lee S.-W.
    Nuclear Medicine and Molecular Imaging, 2017, 51 (4) : 297 - 303
  • [24] Molecular imaging agents for SPECT (and SPECT/CT)
    Gnanasegaran, Gopinath
    Ballinger, James R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S26 - S35
  • [25] Impact of hybrid SPECT/CT imaging in the diagnosis and the management of osteoid osteoma
    Matrane, A.
    Bsiss, M. A.
    El Issami, S.
    Hiroual, S.
    Doubli, S. Bennani
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2013, 37 (09): : 405 - 410
  • [26] LOCALIZATION AND IDENTIFICATION OF PARAPHARYNGEAL METASTASES FROM DIFFERENTIATED THYROID CARCINOMA BY 131I-SPECT/CT
    Qiu, Zhong-Ling
    Xu, Yan-Hong
    Song, Hong-Jun
    Luo, Quan-Yong
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2011, 33 (02): : 171 - 177
  • [27] Clinical Implications of Adding SPECT/CT to Radioiodine Whole-Body Scan in Patients With Differentiated Thyroid Cancer
    Chong, Ari
    Seo, Youngduk
    Bang, Ji-In
    Park, Sohyun
    Kim, Keunyoung
    Hong, Chae Moon
    Choi, Miyoung
    Oh, So Won
    Lee, Sang-Woo
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (03) : 215 - 225
  • [28] 131I imaging in the therapy of differentiated thyroid cancer
    Vija, L. -M.
    Toubert, M. -E.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2012, 36 (01): : 44 - 51
  • [29] Imaging with 124I in differentiated thyroid carcinoma: is PET/MRI superior to PET/CT?
    Binse, I.
    Poeppel, T. D.
    Ruhlmann, M.
    Gomez, B.
    Umutlu, L.
    Bockisch, A.
    Rosenbaum-Krumme, S. J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (06) : 1011 - 1017
  • [30] 124I PET/CT in the pretherapeutic staging of differentiated thyroid carcinoma: comparison with posttherapy 131I SPECT/CT
    Cecile de Pont
    Servais Halders
    Jan Bucerius
    Felix Mottaghy
    Boudewijn Brans
    European Journal of Nuclear Medicine and Molecular Imaging, 2013, 40 : 693 - 700